Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC.

HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC. Abstract Text:

    j a ellerhorstJ A Ellerhorst,w h hildebrandW H Hildebrand,j w cavettJ W Cavett,m a fernandez-vinaM A Fernandez-Vina,s hodgesS Hodges,n poindexterN Poindexter,h fischerH Fischer,e a grimmE A Grimm,

    HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC. Publishing Authors By Initials

    ja ellerhorstJA Ellerhorst,wh hildebrandWH Hildebrand,jw cavettJW Cavett,ma fernandez-vinaMA Fernandez-Vina,s hodgesS Hodges,n poindexterN Poindexter,h fischerH Fischer,ea grimmEA Grimm,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Der Urologe. Ausg. A

    VOLUME: 43 Suppl 3

    Page Numbers: 137

    Journal Abbreviation:

    ISSN: 0340-2592

    DAY: 14

    MONTH: Sep

    YEAR: 2004

    HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 1304110

    HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC.

    AFFILIATION: The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA, jaellerh@mail.mdanderson.com

    Country: Germany

    Germany Research PublicationGermany Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Urologe A

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News